Share-based Compensation (Tables)

9 Months Ended

Sep. 30, 2022

Share Based Compensation Arrangement By Share Based Payment Award [Line Items]

Schedule of Share-based Compensation Expense

The following table summarizes share-based compensation expense included within the Company’s consolidated statements of operations:

		For the three-month period ended September 30,								For the nine-month period ended September 30,
(In thousands)		2022				2021				2022				2021
Research and development expense		$	14			$	225			$	66			$	599
Selling, general and administrative expense			351				627				1,254				1,898
Cost of Sales			(1	)			2				0				18
Total		$	364			$	854			$	1,320			$	2,515

Schedule of Stock Option Activity

A summary of share-based compensation activity for the nine-month period ended September 30, 2022 is presented below:

		Number of Shares (In thousands)				Weighted Average Exercise Price				Weighted Average Remaining Contractual Term				Intrinsic Value (In thousands)
Balance at January 1, 2022			1,186			$	94.38
Granted			97				1.19
Cancelled			(230	)			128.93
Exercised			—				—
Balance at September 30, 2022			1,053			$	78.24				6.0			$	—
Vested and expected to vest at September 30, 2022			1,053			$	78.24				6.0			$	—
Vested and exercisable at September 30, 2022			713			$	113.62				4.5			$	—

Restricted Stock and Performance Stock Unit

Share Based Compensation Arrangement By Share Based Payment Award [Line Items]

Schedule of Restricted Stock and Performance Stock Unit Activity

(In thousands)
Restricted Stock and Performance Stock Units		Number of Shares
Nonvested at January 1, 2022			116
Granted			—
Vested			(103	)
Forfeited			(7	)
Nonvested at September 30, 2022			6